Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Nursing Management of Subcutaneous Daratumumab at Home: A Safe and Effective Procedure for Frail Patients with Multiple Myeloma

Elisa Emanueli Cippitelli, Vincenza Innocenti, Roberta Perazzini, Roberta Talucci, Alessia Fiorini, Giulio Trapè, Maria Gabriela Chavez, Roberta Agrippino, Michela Tarnani, Cristina Mastini, Alessandro Andriani, Marco Montanaro, Roberto Latagliata, Gioia De Angelis, Silvia Ciambella

Blood (2024) 144 (Supplement 1): 7616.

https://doi.org/10.1182/blood-2024-208726

Published: 2024

Journal Articles

Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report

Blood (2023) 142 (Supplement 1): 7242.

https://doi.org/10.1182/blood-2023-187362

Published: 2023

Journal Articles

Domiciliary Nursing Management for Patients Affected By Multiple Myeloma during Covid-19 Pandemia in the Viterbo Home Care Unit: Data Analysis from March 2020 to March 2022

Blood (2022) 140 (Supplement 1): 2404–2405.

https://doi.org/10.1182/blood-2022-164683

Published: 2022

Journal Articles

Nursing Management of Frail Patients with Hematologic Malignancies during COVID-19 Pandemia in the Viterbo Domiciliary Care Unit: Data Analysis from March 2020 to March 2021

Blood (2021) 138 (Supplement 1): 3022.

https://doi.org/10.1182/blood-2021-150276

Published: 2021

Journal Articles

Azacytidine Treatment in Patients with Acute Myeloid Leukemia/High-Risk Myelodysplastic Syndrome: Day-Hospital Management Compared to Home Care Setting

Blood (2021) 138 (Supplement 1): 4042.

https://doi.org/10.1182/blood-2021-149733

Published: 2021

Journal Articles

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Javid Gaziev, Antonella Isgro, MD, Katia Paciaroni, MD, Marco Marziali, MD, Gioia De Angelis, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD

Blood (2018) 132 (Supplement 1): 5777.

https://doi.org/10.1182/blood-2018-99-109764

Published: 2018

Journal Articles

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Javid Gaziev, Antonella Isgrò, MD, Pietro Sodani, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Marziali, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD, Tiziana Gallucci, PhD, Guido Lucarelli, MD

Blood (2017) 130 (Supplement 1): 663.

https://doi.org/10.1182/blood.V130.Suppl_1.663.663

Published: 2017

Journal Articles

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Javid Gaziev, MD, Antonella Isgro, MD, Marco Marziali, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 3468.

https://doi.org/10.1182/blood.V128.22.3468.3468

Published: 2016

Journal Articles

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Javid Gaziev, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Marco Marziali, MD, Marco Andreani, PhD, Cecilia Alfieri, MD, Michela Ribersani, MD, Guido Lucarelli, MD

Blood (2016) 128 (22): 2289.

https://doi.org/10.1182/blood.V128.22.2289.2289

Published: 2016

Journal Articles

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Antonella Isgro, MD, Javid Gaziev, Pietro Sodani, MD, Marco Andreani, PhD, Manuela Testi, PhD, Katia Paciaroni, MD, Cristiano Gallucci, MD, Gioia De Angelis, MD, Marco Marziali, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Olufemi O Akinyanju, T. Thompson Wakama, Festus Olusola Olowoselu, Guido Lucarelli, MD

Blood (2015) 126 (23): 4598.

https://doi.org/10.1182/blood.V126.23.4598.4598

Published: 2015

Journal Articles

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Javid Gaziev, MD, Gioia De Angelis, MD, Antonella Isgro, MD, Pietro Sodani, MD, Marco Marziali, MD, Katia Paciaroni, MD, Marco Andreani, PhD, Manuela Testi, PhD, Cristiano Gallucci, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Maria Troiano, PhD, Aldo Morrone, MD, Guido Lucarelli, MD

Blood (2015) 126 (23): 620.

https://doi.org/10.1182/blood.V126.23.620.620

Published: 2015

Journal Articles

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Adlette Inati, MD, Javid Gaziev, MD, Hussein A Abbas, PhD, Serge Korjian, BSc, Yazan Daaboul, BSc, Mario Kahale, MD, Katia Paciaroni, MD, Gioia de Angelis, MD, Ali T Taher, MD, Therese Abi Nasr, MD, Suzan Koussa, MD, Guido Lucarelli, MD

Blood (2013) 122 (21): 5505.

https://doi.org/10.1182/blood.V122.21.5505.5505

Published: 2013

Journal Articles

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Javid Gaziev, Marco Marziali, Antonella Isgro, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Marco Andreani, BSc, Manuela Testi, Michela Ribersani, Luisa Cardarelli, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (21): 2040.

https://doi.org/10.1182/blood.V122.21.2040.2040

Published: 2013

Journal Articles

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Javid Gaziev, Marco Marziali, Antonella Isgrò, Pietro Sodani, Katia Paciaroni, Cristiano Gallucci, Marco Andreani, Manuela Testi, Gioia De Angelis, Cecilia Alfieri, Luisa Cardarelli, Michela Ribersani, Daniele Armiento, Guido Lucarelli

Blood (2013) 122 (15): 2751–2756.

https://doi.org/10.1182/blood-2013-07-513473

Published: 2013

Journal Articles

Decreased Apoptosis in Bone Marrow of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Antonella Isgrò, Marco Marziali, Pietro Sodani, Javid Gaziev, MD, Daniela Fraboni, Katia Paciaroni, Maria Domenica Simone, Gioia De Angelis, Cecilia Alfieri, Cristiano Gallucci, Andrea Roveda, Fabio Torelli, Luisa Cardarelli, Michela Ribersani, Guido Lucarelli

Blood (2012) 120 (21): 4751.

https://doi.org/10.1182/blood.V120.21.4751.4751

Published: 2012

Journal Articles

Rapid Increase of CD8+ T Cell Count in Peripheral Blood of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Antonella Isgrò, Marco Marziali, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Maria Domenica Simone, Gioia De Angelis, Cecilia Alfieri, Cristiano Gallucci, Andrea Roveda, Fabio Torelli, Luisa Cardarelli, Michela Ribersani, Guido Lucarelli

Blood (2012) 120 (21): 4769.

https://doi.org/10.1182/blood.V120.21.4769.4769

Published: 2012

Journal Articles

A Novel Treatment Protocol Successfully Prevented Graft Rejection and Improved Disease-Free Survival in Class 3 Children with Thalassemia

Javid Gaziev, Pietro Sodani, Antonella Isgrò, Marco Marziali, Maria Domenico Simone, Fabio Torelli, Marco Andreani, Manuela Testi, Katia Paciaroni, Cristiano Gallucci, Andrea Roveda, Gioia De Angelis, Cecilia Alfieri, Guido Lucarelli

Blood (2011) 118 (21): 150.

https://doi.org/10.1182/blood.V118.21.150.150

Published: 2011

Journal Articles

Purified T-depleted, CD34 + peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia

Blood (2010) 115 (6): 1296–1302.

https://doi.org/10.1182/blood-2009-05-218982

Published: 2010

Journal Articles

Late-Onset Hemorrhagic Cystitis in Children After Hematopoietic Stem Cell Transplantation (HSCT) for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir (CDV).

Javid Gaziev, Guido Lucarelli, Stefano Germani, Pierpaolo Paba, Carlo Federico Perno, Roberto Miano, Pierluigi Bove, Pietro Sodani, Antonella Isgro, Marco Marziali, Paola Polchi, Aldo Montuoro, Katia Paciaroni, Cristiano Gallucci, Maria Domenica Simone, Andrea Roveda, Gioia De Angelis, Cecilia Alfieri

Blood (2009) 114 (22): 1133.

https://doi.org/10.1182/blood.V114.22.1133.1133

Published: 2009

Journal Articles

Clinical Outcomes and Pharmacokinetics of Targeted Intravenous Busulfan in Children Receiving Stem Cell Transplantation for Thalassemia.

Blood (2008) 112 (11): 1117.

https://doi.org/10.1182/blood.V112.11.1117.1117

Published: 2008

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Nursing Management of Subcutaneous Daratumumab at Home: A Safe and Effective Procedure for Frail Patients with Multiple Myeloma

Subcutaneous Daratumumab at Home Is a Safe and Effective Procedure for Frail Patients with Multiple Myeloma: A Myelhome Project Report

Domiciliary Nursing Management for Patients Affected By Multiple Myeloma during Covid-19 Pandemia in the Viterbo Home Care Unit: Data Analysis from March 2020 to March 2022

Nursing Management of Frail Patients with Hematologic Malignancies during COVID-19 Pandemia in the Viterbo Domiciliary Care Unit: Data Analysis from March 2020 to March 2021

Azacytidine Treatment in Patients with Acute Myeloid Leukemia/High-Risk Myelodysplastic Syndrome: Day-Hospital Management Compared to Home Care Setting

Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Evaluation of the Impact of Anti-Thymocyte Globulin on Post-Transplant Outcomes in Sickle Cell Anemia Patients Undergoing BMT from HLA-Identical Sibling Donors

Optimal Outcomes after Second Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Recurrence Following Graft Failure/Rejection of the First Graft

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

Outcome Of Bone Marrow Transplantation In Lebanese Children With β-Thalassemia Major

Bone Marrow Transplantation For Thalassemia Using Related Other Than HLA- Identical Siblings: Improved Transplant Outcomes With a Novel Approach

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

Decreased Apoptosis in Bone Marrow of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

Rapid Increase of CD8+ T Cell Count in Peripheral Blood of Pediatric Patients After HLA-Identical Stem Cell Transplantation for African Sickle Cell Anemia

A Novel Treatment Protocol Successfully Prevented Graft Rejection and Improved Disease-Free Survival in Class 3 Children with Thalassemia

Purified T-depleted, CD34 + peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia

Late-Onset Hemorrhagic Cystitis in Children After Hematopoietic Stem Cell Transplantation (HSCT) for Thalassemia and Sickle Cell Anemia: A Prospective Evaluation of Polyoma (BK) Virus Infection and Treatment with Cidofovir (CDV).

Clinical Outcomes and Pharmacokinetics of Targeted Intravenous Busulfan in Children Receiving Stem Cell Transplantation for Thalassemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only